The late-breaking (LB) category is intended to recognize high impact research whose results were not available by the general abstract submission deadline. Only three LB abstracts will be selected for oral presentation at the MSMilan2023 Congress.
Abstracts must be novel and not previously published, presented or submitted for consideration at another meeting. The presenting author must be registered and present at the Congress to be eligible for a LB presentation.
A few years ago, the CHI conference began to put more emphasis on a set of presentations called “Late Breakers,” which were arguably more clinically relevant and important than most other original research at the meeting. While it’s understandable that the LB presentations are of particular interest, it’s worth remembering that there is a large number of clinically relevant and important studies that occur in other sessions, as well.
The LB program is an opportunity to showcase new research that will impact interventional cardiology practice, whether it’s primary results from a randomized trial; subgroup, post hoc or prespecified analysis of a randomized trial; or observational studies of devices or treatments. Ideally, these studies will have sufficient data to support their claims and warrant a larger study of longer duration. LB abstracts should contain the study design, patient population or sample, procedures used to collect and analyze data, and endpoints (i.e., the primary and secondary outcomes). Please note that LB abstracts should not be presented as full-length papers at this time.